Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | MMP3 | P08254 | 6/20 | 0.46 |
| ▸ | MMP1 | P03956 | 2/20 | 0.46 |
| ▸ | CTSK | P43235 | 4/20 | 0.46 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1301358 | 0.93 | SIRT5 (0.54) | SIRT5PTPN1MMP3MMP1CTSK | |
| SCHEMBL7071339 | 0.92 | CTSK (0.56) | SIRT5MMP3MMP1CTSKCAPN1 | |
| SCHEMBL3868962 | 0.88 | SIRT5 (0.52) | SIRT5MMP3MMP1 | |
| SCHEMBL3868955 | 0.88 | SIRT5 (0.52) | SIRT5MMP3MMP1 | |
| SCHEMBL3307438 | 0.85 | MMP3 (0.62) | SIRT5MMP3MMP1CTSK | |
| SCHEMBL29779887 | 0.85 | MMP3 (0.62) | SIRT5MMP3MMP1CTSK | |
| SCHEMBL1301778 | 0.83 | TDP1 (0.49) | SIRT5 | |
| SCHEMBL2339174 | 0.78 | MMP3 (0.52) | PTPN1MMP3 | |
| SCHEMBL1301777 | 0.76 | TDP1 (0.50) | SIRT5MMP3 | |
| SCHEMBL20827880 | 0.75 | CAPN1 (0.52) | PTPN1CTSKCAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110269162-A1 | UBIQUITIN PROTEASOME SYSTEM PROFILING FOR DIAGNOSIS OF CHRONIC LIVER DISEASE | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2011-11-03 | — | — | US | disclosed |
| WO-2011069009-A1 | POLYUBIQUITIN LEVELS AS A PROGNOSTIC INDICATOR IN LEUKEMIA | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2011-06-09 | — | — | WO | disclosed |
| WO-2011028489-A1 | UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2011-03-10 | — | — | WO | disclosed |
| WO-2011028488-A1 | UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR PROLIFERATIVE HEMATOLOGICAL DISORDERS | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2011-03-10 | — | — | WO | disclosed |
| US-20110053199-A1 | UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2011-03-03 | — | — | US | disclosed |
| US-20110053198-A1 | UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR PROLIFERATIVE HEMATOLOGICAL DISORDERS | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2011-03-03 | — | — | US | disclosed |
| US-20110053197-A1 | UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2011-03-03 | — | — | US | disclosed |